April 14, 2017
FPMAJ Chairman Masayo Tada The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) is poised to press for the permanent introduction of the so-called price maintenance premium for on-patent drugs as its top priority in discussions for the proposed drug...read more